Eli Lilly & Company in the IMPRESS study
Eli Lilly & Company is now part of the national Norwegian IMPRESS study.
This author has yet to write their bio.Meanwhile lets just say that we are proud CONNECT contributed a whooping 277 entries.
Eli Lilly & Company is now part of the national Norwegian IMPRESS study.
Statsbudsjettet for 2022 inneholder lite for kreftpasienter og innovasjon innen kreftbehandling.
Did you know that Oslo Cancer Cluster is a changemaker?
The Research Council of Norway recently awarded grants to several innovation projects in the industrial sector. One of the lucky companies was the newcomer NordicRWE.